We hypothesise that the key feature of emulsifier-treated M-SHIME microbiotas that drove their ability to promote inflammation following transplant was their greater ability to encroach upon host ...
Investors in Ibex Biosciences will support a company on the cutting edge of biotech research. The company's approach of developing therapies from scratch offers a unique value proposition in the ...